Overview
Nobutoshi Esaki practices practicing medicine in Nagoya, Japan.
Their clinical expertise encompasses Pancreatic Cancer, Osteosarcoma, Bone Tumor, and Small Cell Lung Cancer (SCLC).
They are actively involved in clinical research, co-authoring 22 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nobutoshi Esaki
Is Nobutoshi Esaki a top-rated expert for Pancreatic Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Nobutoshi Esaki is classified as an Experienced expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nobutoshi Esaki participate in research or clinical trials?
Yes. Nobutoshi Esaki has published 22 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Nobutoshi Esaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone TumorEsaki isExperienced. Learn about Bone Tumor.
- OsteosarcomaEsaki isExperienced. Learn about Osteosarcoma.
- Pancreatic CancerEsaki isExperienced. Learn about Pancreatic Cancer.
- Small Cell Lung Cancer (SCLC)Esaki isExperienced. Learn about Small Cell Lung Cancer (SCLC).